Related Experiment Video
Updated: Mar 6, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Cyanotic congenital heart disease and atherosclerosis
Julie Bjerre Tarp1,2, Annette Schophuus Jensen1, Thomas Engstrøm1
1Department of Cardiology, the Heart Centre, Copenhagen University Hospital, Copenhagen, Denmark.
Insights
Patients with cyanotic heart disease (CCHD) may have a reduced risk of atherosclerosis. This review explores the prevalence and potential causes of this protective effect in aging CCHD patients.
Area of Science:
- Cardiology
- Vascular Biology
- Congenital Heart Disease
Background:
- Improved treatments have led to an aging population with cyanotic congenital heart disease (CCHD).
- Atherosclerosis risk increases with age, posing a concern for this growing patient group.
- Previous studies suggest CCHD patients may be protected against atherosclerosis, but evidence is limited.
Purpose of the Study:
- To review the current understanding of atherosclerosis prevalence in CCHD patients.
- To explore potential underlying mechanisms for a reduced risk of atherosclerosis in CCHD.
- To identify knowledge gaps and guide future research in this area.
Main Methods:
- Literature review of studies investigating atherosclerosis in patients with CCHD.
- Analysis of findings related to coronary arteries, carotid intima-media thickness, and plasma cholesterol levels.
- Synthesis of evidence to evaluate the protective effect against atherosclerosis.
Main Results:
- Coronary arteries in CCHD patients appear free from plaques and stenosis.
- Reduced carotid intima-media thickness observed in CCHD populations.
- Lower total plasma cholesterol levels noted, suggesting a potentially decreased atherosclerosis risk.
Conclusions:
- Cyanotic congenital heart disease (CCHD) may confer a degree of protection against atherosclerosis.
- Further research is needed to elucidate the mechanisms behind this observed reduced risk.
- Understanding this phenomenon is crucial for managing long-term cardiovascular health in aging CCHD survivors.
Abstract:
Improved treatment options in paediatric cardiology and congenital heart surgery have resulted in an ageing population of patients with cyanotic congenital heart disease (CCHD). The risk of acquired heart disease such as atherosclerosis increases with age.Previous studies have speculated whether patients with CCHD are protected against atherosclerosis. Results have shown that the coronary arteries of patients with CCHD are free from plaques and stenosis. Decreased carotid intima-media thickness and low total plasma cholesterol may indicate a reduced risk of later development of atherosclerosis. However, the evidence is still sparse and questionable, and a reasonable explanation for the decreased risk of developing atherosclerosis in patients with CCHD is still missing.This review provides an overview of what is known about the prevalence and potential causes of the reduced risk of atherosclerosis in patients with CCHD.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Rheumatic Heart Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

